Differential toxicological endpoints of di(2-ethylhexyl) phthalate (DEHP) exposure in MCF-7 and MDA-MB-231 cell lines: Possible estrogen receptor α (ERα) independent modulations

Indian Journal of Experimental Biology

Volumn 52, Issue 11, 2014, Pages 1052-1061

  Das, Mihir Tanay ^a   Singh, Manoj Kumar ^a   Thakur, Indu Shekhar ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Cell cycle; DEHP; Estrogen receptors ; Label free quantification; Secretome

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; LACTOFERRIN; LTF PROTEIN, HUMAN; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; POLLUTANT; TAMOXIFEN; TUMOR PROTEIN;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; BREAST TUMOR; CELL CYCLE; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; DEVICES; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MASS SPECTROMETRY; MCF 7 CELL LINE; NEOPLASM; PATHOLOGY; PHYSIOLOGY; POLLUTANT; PROTEOMICS; SECRETION (PROCESS); TOXICITY; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DIETHYLHEXYL PHTHALATE; ENVIRONMENTAL POLLUTANTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTOFERRIN; MASS SPECTROMETRY; MCF-7 CELLS; MICROCHEMISTRY; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PROTEOMICS; TAMOXIFEN;

EID: 84908564315     PISSN: 00195189     EISSN: 09751009     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. USFDA, Safety assessment of di (2-ethylhexyl) phthalate (DEHP) release from medical devices. US Food and drug administration. Washington, DC, 2002. http://www.fda.gov/cdrh/ost/dehp-pvc.pdf.
2. ATSDR, Toxicological Profile for Di (2-ethylhexyl) Phthalate (Agency for Toxic Substances and Disease. Atlanta, GA) 2002.
3. Clark KE, David RM, Guinn R, Kramarz KW, Lampi MA & Staples CA, Modeling human exposure to phthalate esters: A comparison of indirect and biomonitoring estimation methods, Hum Ecol Risk Assess, 17 (2011) 923.
4. Okubo T, Suzuki T, Yokoyama Y, Kano K & Kano I, Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro, Biol Pharm Bull, 26 (2003) 1219.
5. Kim IY, Han SY & Moon A, Phthalates inhibit tamoxifeninduced apoptosis in MCF-7 human breast cancer cells, J Toxicol Environ Health A, 67 (2004) 2025.
6. Harris C A, Henttu P, Parker M G & Sumpter J P, The estrogenic activity of phthalate esters in vitro, Environ Health Perspect, 105 (1997) 802.
7. Shen O, Du G, Sun H, Wu W, Jiang Y, Song L & Wang X, Comparison of in vitro hormone activities of selected phthalates using reporter gene assays, Toxicol Lett, 191 (2009) 9.
8. Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, Wang SC & Tsai EM, Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway, FASEB J, 26 (2012) 778.
9. Minervini F, Giannoccaro A, Cavallini A & Angelo V, Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters, Toxicol Lett, 159 (2005) 272.
10. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N & Serrano FO, The E-screen assay as a tool to identify estrogens: An update on estrogenic environmental pollutants, Environ Health Perspect, 103 (1995) 113.
11. Vanparys C, Maras M, Lenjou M, Robbens J, Van Bockstaele D, Blust R & De Coen W, Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells, Toxicol In Vitro, 20 (2006) 1238.
12. Furr BJA & Jordan VC, The pharmacology and clinical uses of tamoxifen, Pharmacol Ther, 25 (1984) 127.
13. McKeon VA, The breast cancer prevention trial: Should women at high risk take tamoxifen? J Obstet Gynecol Neonatal Nurs, 28 (1999) 34.
14. Radmacher MD & Simon R, Estimation of tamoxifens’s efficiency for preventing the formation and growth of breast tumors, J Natl Cancer Inst, 92 (2000) 48.
15. Otto A, Paddenberg R, Schubert S & Mannhertz H, Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin, J Cancer Res Clin Oncol, 22 (1996) 603.
16. Ferlini C, Scambia G, Marone M, Distefano M, Gaggini C, Ferrandina G, Fattorossi A, Isola G, Benedetti, Pancini P & Mancuso S, Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines, Br J Cancer, 79 (1999) 257.
17. Teixeira C, Reed JC & Pratt MA, Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells, Cancer Res, 55 (1995) 3902.
18. Monteoliva L & Albar JP, Differential proteomics: an overview of gel and non-gel based approaches, Brief Funct Genomic Proteomic, 3 (2004) 220.
19. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH & Aebersold R, Quantitative analysis of complex protein mixtures using isotope coded affinity tags, Nat Biotechnol, 17 (1999) 994.
20. Brioschi M, Lento S, Tremoli E & Banfi C, Proteomic analysis of endothelial cell secretome: A mean of studying the pleiotropic effects of Hmg-CoA reductase inhibitors, J Proteomics, 78 (2013) 346.
21. Xue H, Lu B, Zhang J, Wu M, Huang Q, Wu Q, Sheng H, Wu D, Hu J & Lai M, Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach, J Proteome Res, 9 (2010) 545.
22. Payne J, Jones C, Lakhani S & Kortenkamp A, Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens, Sci Total Environ, 248 (2000) 51.
23. Kim HS, Ishizaka M, Kazusaka A & Fujita F, Di-(2-ethylhexyl) phthalate suppresses tamoxifen-induced apoptosis in GH3 pituitary cells, Arch Toxicol, 81 (2007) 27.
24. Zheng A, Kallio A & Harkonen P, Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen, Endocrinology, 148 (2007) 2764.
25. Krishan A, Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining, J Cell Biol, 66 (1975) 188.
26. Geromanos SJ, Vissers JP, Silva JC, Dorschel CA, Li GZ, Gorenstein MV, Bateman RH & Langridge JI, The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS, Proteomics, 9 (2009) 1683.
27. Li GZ, Vissers JP, Silva JC, Golick D, Gorenstein MV & Geromanos SJ, Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures, Proteomics, 9 (2009) 1696.
28. Vyhlidal C, Li X & Safe S, Estrogen regulation of transferrin gene expression in MCF-7 human breast cancer cells, J Mol Endocrinol, 29 (2002) 305.
29. Teng CT, Lactoferrin: The path from protein to gene, Biometals, 23 (2010) 359.
30. Liu Y & Teng CT, Estrogen response module of the mouse lactoferrin gene contains overlapping chicken ovalbumin upstream promoter transcription factor and estrogen receptorbinding elements, Mol Endocrinol, 6 (1996) 355.
31. Vandewalle B, Hornez L, Revillion F & Lefebvre J, Secretion of transferrin by human breast cancer cells, Biochem Biophysl Res Commun, 163 (1989) 149.
32. Yi JK, Chang JW, Han W, Lee JW, Ko E, Kim DH, Bae J-Y, Yu J, Lee C, Yu M-H & Noh D-U, Autoantibody to tumor antigen, alpha 2-HS glycoprotein: A novel biomarker of breast cancer screening and diagnosis, Cancer Epidemiol Biomarkers Prev, 18 (2009) 1357.
33. Choi S, Park SY, Jeong J, Cho E, Phark S, Lee M, Kwak D, Lim JY, Jung WW & Sul D, Identification of toxicological biomarkers of di(2-ethylhexyl) phthalate in proteins secreted by HepG2 cells using proteomic analysis, Proteomics, 10 (2010) 1831.
34. Hasmall S, Orphanides G, James N, Pennie W, Hedley K, Soames A, Kimber I & Roberts R, Downregulation of lactoferrin by PPARα ligands: Role in perturbation of hepatocyte proliferation and apoptosis, Toxicol Sci, 68 (2002) 304.
35. Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD & Balkwill FR, Expression of tumor necrosis factor (TNF-α) and its receptors in benign and malignant breast tissue, Int J Cancer, 56 (1994) 777.
36. Balkwill F, Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor, 13 (2002) 135.
37. Machnicki M, Zimecki M & Zagulski T, Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo, Int J Exp Pathol, 74 (1993) 433.
38. Zimecki M, Właszczyk A, Zagulski T & Kübler A, Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery, Arch Immunol Ther Exp, 42 (1998) 97.